Literature DB >> 3580252

Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor.

O Walker, A H Dawodu, L A Salako, G Alván, A O Johnson.   

Abstract

The single dose disposition of chloroquine was studied in five children with kwashiorkor and six normal control children after an oral dose of 10 mg kg-1 of chloroquine base. Plasma concentrations of chloroquine and its main metabolite were assayed by high performance liquid chromatography (h.p.l.c.). Chloroquine was detectable for up to 21 days in all the subjects. Chloroquine was detectable in all the subjects within 30 min after giving the drug except in one subject. Peak levels were reached between 0.5 and 8 h in all the subjects (with no significant difference in the tmax between the two groups of children). Peak plasma chloroquine concentrations in the children with kwashiorkor varied from 9 ng ml-1 to 95 ng ml-1 (mean 40 +/- 34 ng ml-1). Peak chloroquine concentrations in the controls varied between 69 ng ml-1 and 330 ng ml-1 (mean 134 +/- 99 ng ml-1). The mean AUC in the kwashiorkor children was significantly lower than the mean AUC in the control children (P less than 0.001). Peak plasma desethylchloroquine concentrations in the children with kwashiorkor varied between 3 and 13 ng ml-1 (mean 6 +/- 9 ng ml-1) while in the controls the concentrations varied between 14 and 170 ng ml-1 (mean 50 +/- 61 ng ml-1). There was no significant difference in the half-life of chloroquine between the kwashiorkor children and the normal control children. The possible influence of a different binding and distribution pattern of chloroquine in kwashiorkor could not be assessed in this study.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3580252      PMCID: PMC1386097          DOI: 10.1111/j.1365-2125.1987.tb03077.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  15 in total

1.  Protein-losing enteropathy and malabsorption in acute measles enteritis.

Authors:  J F Dossetor; H C Whittle
Journal:  Br Med J       Date:  1975-06-14

2.  Chloroquine metabolism in kwashiorkor.

Authors:  B A Wharton; E W McChesney
Journal:  J Trop Pediatr (1967)       Date:  1970-09

Review 3.  The biochemistry and physiology of kwashiorkor and marasmus.

Authors:  W A Coward; P G Lunn
Journal:  Br Med Bull       Date:  1981-01       Impact factor: 4.291

4.  The influence of aflatoxins on child health in the tropics with particular reference to kwashiorkor.

Authors:  R G Hendrickse
Journal:  Trans R Soc Trop Med Hyg       Date:  1984       Impact factor: 2.184

5.  Sensitive method for the determination of chloroquine and its metabolite desethyl-chloroquine in human plasma and urine by high-performance liquid chromatography.

Authors:  Y Bergqvist; M Frisk-Holmberg
Journal:  J Chromatogr       Date:  1980-11-14

6.  Chloramphenicol pharmacokinetics in Ethiopian children of differing nutritional status.

Authors:  M Eriksson; L Paalzow; P Bolme; T W Mariam
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

7.  Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria.

Authors:  O Walker; A H Dawodu; A A Adeyokunnu; L A Salako; G Alvan
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

8.  Characterization of chloroquine plasma protein binding in man.

Authors:  O Walker; D J Birkett; G Alván; L L Gustafsson; F Sjöqvist
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

9.  Variations in drug free fraction during alcohol withdrawal.

Authors:  P Sandor; C A Naranjo; V Khouw; E M Sellers
Journal:  Br J Clin Pharmacol       Date:  1983-04       Impact factor: 4.335

10.  Kinetics of the uptake and elimination of chloroquine in children with malaria.

Authors:  S A Adelusi; A H Dawodu; L A Salako
Journal:  Br J Clin Pharmacol       Date:  1982-10       Impact factor: 4.335

View more
  16 in total

Review 1.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

Review 2.  Pharmacokinetics of quinine, chloroquine and amodiaquine. Clinical implications.

Authors:  S Krishna; N J White
Journal:  Clin Pharmacokinet       Date:  1996-04       Impact factor: 6.447

Review 3.  A systematic review of pharmacokinetics studies in children with protein-energy malnutrition.

Authors:  Kazeem A Oshikoya; Helen M Sammons; Imti Choonara
Journal:  Eur J Clin Pharmacol       Date:  2010-06-16       Impact factor: 2.953

4.  Altered pharmacokinetics and dynamics of apomorphine in the malnourished rat: modeling of the composed relationship between concentration and heart-rate response.

Authors:  E Bredberg; L K Paalzow
Journal:  Pharm Res       Date:  1990-04       Impact factor: 4.200

Review 5.  Influences of diet and nutrition on clinical pharmacokinetics.

Authors:  K E Anderson
Journal:  Clin Pharmacokinet       Date:  1988-06       Impact factor: 6.447

6.  Reduced efficacy of intermittent preventive treatment of malaria in malnourished children.

Authors:  Ina Danquah; Ekkehart Dietz; Philipp Zanger; Klaus Reither; Peter Ziniel; Ulrich Bienzle; Frank P Mockenhaupt
Journal:  Antimicrob Agents Chemother       Date:  2009-02-17       Impact factor: 5.191

7.  Pharmacokinetics of quinine in African children suffering from kwashiorkor.

Authors:  L A Salako; A Sowunmi; F O Akinbami
Journal:  Br J Clin Pharmacol       Date:  1989-08       Impact factor: 4.335

Review 8.  Drug metabolism and pharmacokinetics in malnourished children.

Authors:  K Krishnaswamy
Journal:  Clin Pharmacokinet       Date:  1989       Impact factor: 6.447

9.  A multi-center, open-label trial to compare the efficacy and pharmacokinetics of Artemether-Lumefantrine in children with severe acute malnutrition versus children without severe acute malnutrition: study protocol for the MAL-NUT study.

Authors:  Lise Denoeud-Ndam; Alassane Dicko; Elisabeth Baudin; Ousmane Guindo; Francesco Grandesso; Issaka Sagara; Estrella Lasry; Pedro Pablo Palma; Angeles M Lima Parra; Kasia Stepniewska; Abdoulaye A Djimde; Karen I Barnes; Ogobara K Doumbo; Jean-François Etard
Journal:  BMC Infect Dis       Date:  2015-06-12       Impact factor: 3.090

10.  Pathophysiological changes that affect drug disposition in protein-energy malnourished children.

Authors:  Kazeem A Oshikoya; Idowu O Senbanjo
Journal:  Nutr Metab (Lond)       Date:  2009-12-01       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.